Precision BioSciences, Inc (DTIL) Stock Price

7.06 ▼ -0.38 (-5.11%)
Open: 7.31 Vol: 108.83K Day's range: 6.97 - 7.42 Oct 30, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
DTIL Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 7.06▼ 7.09▼ 7.13▼ 7.03▲ 6.50▲
MA10 7.05▲ 7.19▼ 7.23▼ 6.81▲ 6.78▲
MA20 7.12▼ 7.28▼ 7.29▼ 6.53▲ 7.24▼
MA50 7.19▼ 7.13▼ 6.88▲ 6.90▲ 6.18▲
MA100 7.37▼ 6.87▲ 6.55▲ 7.22▼ 5.67▲
MA200 7.14▼ 6.56▲ 6.46▲ 6.54▲ 10.65▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ -0.049▼ -0.070▼ 0.141▲ -0.160▼
RSI 39.017▼ 40.664▼ 47.899▼ 55.824▲ 51.690▲
STOCH 65.607     22.940     19.613▼ 76.376     21.308    
WILL %R -55.556     -83.158▼ -90.000▼ -36.190     -62.982    
CCI -18.709     -114.936▼ -116.465▼ 104.592▲ -2.298    
Latest Filters Detected On DTIL
▲ MACD $DTIL MACD(12,26,9) Crossed Above Zero Set Alert
MA $DTIL Price Crossed Above MA(50) Set Alert
▲ BREAK $DTIL Price Breaks 30 Days High Set Alert
▲ BREAK $DTIL Price Breaks 20 Days High Set Alert
▲ BREAK $DTIL Price Breaks 10 Days High Set Alert
Precision BioSciences, Inc News
Precision BioSciences to Report Third Quarter 2026 Financial Results on November 3, 2026
Thursday, October 29, 2026 01:30 AM
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
Precision BioSciences Inc (DTIL)
Wednesday, October 28, 2026 01:00 PM
Precision BioSciences, Inc. (Nasdaq: DTIL) announced that it dosed the first patient in August in its Phase 1/2 FUNCTION-DMD... DURHAM, N.C. - Precision BioSciences Inc. (NASDAQ:DTIL) dosed the first ...
Precision BioSciences Announces Presentation of Initial Safety Data from the Phase 1 ELIMINATE-B Trial Evaluating PBGENE-HBV at the 2025 European Association for the Study of ...
Tuesday, May 06, 2025 05:00 PM
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...
DTIL historical stock data
date open high low close volume
30/10/26 7.31 7.42 6.97 7.06 108,829
29/10/26 7.50 7.82 7.37 7.44 165,713
28/10/26 6.76 7.50 6.66 7.47 188,566
27/10/26 6.39 6.81 6.29 6.79 164,247
26/10/26 6.68 6.8763 6.37 6.41 266,677
23/10/26 6.73 6.73 6.29 6.64 275,388
22/10/26 6.70 6.925 6.58 6.78 132,427
21/10/26 6.62 6.86 6.545 6.71 231,039
20/10/26 6.09 6.67 6.09 6.56 210,894
19/10/26 5.80 6.21 5.77 6.19 176,468
Quote Details
52wk Low:3.53
52wk High:9.62
Vol:108.83K
Avg Vol(3m):5.4M
1Y Chng:+37.35%
1M Chng:+8.62%
Add to Watch List
More Information
Index US Composite
Market Cap. 205.36M